EXAGEN INC. (XGN) Current Ratio
- Current ratio · latest quarter: Value 3.18×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.18× | Current assets / current liabilities. $42.86M ÷ $13.46M ≈ 3.18× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 42.86M USD | Assets, Current |
| Current obligations | 13.46M USD | Liabilities, Current |
| Cash and equivalents | 24.59M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 12.41M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 4.44M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 517.00K USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $42.86M | $13.46M | $24.59M | (m) | $12.41M | (m) | $4.44M | $517.00K | 3.18× |
| 2026-03-31 | $43.58M | $12.56M | $21.51M | (m) | $15.77M | (m) | $4.16M | $580.00K | 3.47× |
| 2025-12-31 | $48.89M | $14.16M | $32.22M | (m) | $10.86M | (m) | $4.15M | $643.00K | 3.45× |
| 2025-09-30 | $52.59M | $12.89M | $35.65M | (m) | $11.09M | (m) | $3.56M | $680.00K | 4.08× |
| 2025-06-30 | $50.99M | $10.29M | $30.03M | (m) | $14.27M | (m) | $2.51M | $667.00K | 4.95× |
| 2025-03-31 | $32.51M | $13.99M | $11.19M | (m) | $14.73M | (m) | $4.51M | $2.54M | 2.32× |
| 2024-12-31 | $36.45M | $13.51M | $22.04M | (m) | $7.83M | (m) | $4.14M | $423.00K | 2.70× |
| 2024-09-30 | $35.56M | $8.78M | $22.04M | (m) | $9.39M | (m) | $1.10M | $430.00K | 4.05× |
| 2024-06-30 | $40.79M | $9.45M | $24.48M | (m) | $11.70M | (m) | $2.33M | $423.00K | 4.32× |
| 2024-03-31 | $42.40M | $8.78M | $27.27M | (m) | $10.90M | (m) | $1.47M | $268.00K | 4.83× |
| 2023-12-31 | $47.84M | $11.90M | $36.49M | (m) | $6.55M | (m) | $3.13M | $264.00K | 4.02× |
| 2023-09-30 | $48.91M | $10.12M | $28.45M | (m) | $17.04M | (m) | $1.66M | $261.00K | 4.83× |
| 2023-06-30 | $51.27M | $8.60M | $31.47M | (m) | $16.23M | (m) | $1.31M | $257.00K | 5.96× |
| 2023-03-31 | $65.72M | $9.27M | $52.18M | (m) | $9.30M | (m) | $1.88M | $254.00K | 7.09× |
| 2022-12-31 | $72.61M | $9.62M | $62.39M | (m) | $6.08M | (m) | $3.05M | $190.00K | 7.55× |
| 2022-09-30 | $82.06M | $11.33M | $68.70M | (m) | $10.64M | (m) | $3.67M | (m) | 7.24× |
| 2022-06-30 | $88.16M | $10.05M | $76.39M | (m) | $8.71M | (m) | $3.10M | (m) | 8.77× |
| 2022-03-31 | $103.64M | $11.88M | $89.75M | (m) | $10.91M | (m) | $4.21M | (m) | 8.72× |
| 2021-12-31 | $112.73M | $9.32M | $99.44M | (m) | $9.65M | (m) | $2.49M | $0.00 | 12.10× |
| 2021-09-30 | $118.38M | $8.10M | $106.77M | (m) | $9.21M | (m) | $1.51M | (m) | 14.62× |
| 2021-06-30 | $124.53M | $8.27M | $112.58M | (m) | $8.78M | (m) | $2.45M | (m) | 15.07× |
| 2021-03-31 | $129.37M | $7.88M | $118.05M | (m) | $8.22M | (m) | $2.17M | (m) | 16.41× |
| 2020-12-31 | $70.52M | $8.77M | $57.45M | (m) | $8.91M | (m) | $3.01M | (m) | 8.04× |
| 2020-09-30 | $72.56M | $8.27M | $61.43M | (m) | $9.30M | (m) | $2.45M | (m) | 8.77× |
| 2020-06-30 | $73.46M | $5.75M | $63.70M | (m) | $7.26M | (m) | $1.44M | (m) | 12.77× |
| 2020-03-31 | $77.58M | $7.33M | $68.65M | (m) | $5.84M | (m) | $2.57M | (m) | 10.58× |
| 2019-12-31 | $81.25M | $5.89M | $72.08M | (m) | $5.71M | (m) | $1.48M | (m) | 13.78× |
| 2019-09-30 | $85.75M | $7.66M | $77.83M | (m) | $6.24M | (m) | $1.21M | (m) | 11.19× |
| 2018-12-31 | $21.31M | $8.95M | $13.16M | (m) | $5.95M | (m) | $1.28M | (m) | 2.38× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |